Scott Marshall

1.6k total citations
49 papers, 1.1k citations indexed

About

Scott Marshall is a scholar working on Physiology, Pharmacology and Strategy and Management. According to data from OpenAlex, Scott Marshall has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Pharmacology and 7 papers in Strategy and Management. Recurrent topics in Scott Marshall's work include Pain Mechanisms and Treatments (7 papers), Corporate Social Responsibility Reporting (6 papers) and Statistical Methods in Clinical Trials (6 papers). Scott Marshall is often cited by papers focused on Pain Mechanisms and Treatments (7 papers), Corporate Social Responsibility Reporting (6 papers) and Statistical Methods in Clinical Trials (6 papers). Scott Marshall collaborates with scholars based in United Kingdom, United States and Sweden. Scott Marshall's co-authors include Darrell Brown, Marlene Plumlee, Kathleen Hertz Rupley, Mats O. Karlsson, Jacques Pirenne, Didier Samuel, Lionel Rostaing, Antoni Rimola, A. Mayer and P. Neuhaus and has published in prestigious journals such as American Journal of Epidemiology, Pain and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Scott Marshall

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Marshall United Kingdom 19 211 199 165 161 134 49 1.1k
Joel Owen United States 19 55 0.3× 77 0.4× 15 0.1× 115 0.7× 187 1.4× 73 1.3k
Frank L. Douglas United States 19 165 0.8× 102 0.5× 10 0.1× 15 0.1× 48 0.4× 41 1.4k
Robert Obermaier Germany 17 549 2.6× 119 0.6× 47 0.3× 97 0.6× 21 0.2× 75 1.0k
Richard A. Cohn United States 24 196 0.9× 136 0.7× 61 0.4× 113 0.7× 67 0.5× 71 2.4k
Rezà F. Saidi United States 26 1.2k 5.6× 29 0.1× 621 3.8× 394 2.4× 11 0.1× 121 2.2k
Andrew Charlesworth United Kingdom 27 894 4.2× 21 0.1× 11 0.1× 17 0.1× 86 0.6× 116 5.0k
Helén Anderson Australia 22 490 2.3× 283 1.4× 45 0.3× 2 0.0× 33 0.2× 101 2.3k
Shun‐Chiao Chang United States 23 44 0.2× 92 0.5× 101 0.6× 2 0.0× 34 0.3× 51 1.7k
Vikram Sinha United States 27 422 2.0× 16 0.1× 52 0.3× 12 0.1× 167 1.2× 76 2.4k
David Lawrence United States 25 327 1.5× 14 0.1× 26 0.2× 3 0.0× 78 0.6× 87 3.4k

Countries citing papers authored by Scott Marshall

Since Specialization
Citations

This map shows the geographic impact of Scott Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Marshall more than expected).

Fields of papers citing papers by Scott Marshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Marshall. The network helps show where Scott Marshall may publish in the future.

Co-authorship network of co-authors of Scott Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Marshall. A scholar is included among the top collaborators of Scott Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Marshall. Scott Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marshall, Scott, et al.. (2024). Inter‐regional pharmacokinetics and exposure–response analyses of belimumab in patients with system lupus erythematosus. British Journal of Clinical Pharmacology. 91(2). 374–385. 1 indexed citations
2.
Shoji, Satoshi, et al.. (2023). Prediction of relative change in free nerve growth factor following subcutaneous administration of tanezumab, a novel monoclonal antibody to nerve growth factor. CPT Pharmacometrics & Systems Pharmacology. 12(9). 1358–1370. 1 indexed citations
3.
4.
Patel, Kushang V., Robert R. Allen, Laurie B. Burke, et al.. (2018). Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis. Pain. 159(11). 2245–2254. 28 indexed citations
5.
Kenward, Gary, Scott Marshall, & Karen Irvine. (2017). How much is enough? Using Delphi to explore the clinical-contact-time and return-to-practice needs of military nurses. Nursing Management. 24(2). 20–24. 3 indexed citations
6.
Vase, Lene, Jan Vollert, Nanna Brix Finnerup, et al.. (2015). Predictors of the placebo analgesia response in randomized controlled trials of chronic pain. Pain. 156(9). 1795–1802. 88 indexed citations
7.
Ren, Yupeng, Rujia Xie, Scott Marshall, et al.. (2015). Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteers. European Journal of Clinical Pharmacology. 71(10). 1209–1221. 5 indexed citations
8.
Plumlee, Marlene, Darrell Brown, Rachel M. Hayes, & Scott Marshall. (2010). Voluntary Environmental Disclosure Quality and Firm Value: Further Evidence. SSRN Electronic Journal. 28 indexed citations
9.
Florian, Jeffry, S. Bramwell, Mark J. Field, et al.. (2010). Pharmacokinetic–Pharmacodynamic Analysis of the Static Allodynia Response to Pregabalin and Sildenafil in a Rat Model of Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 334(2). 599–608. 20 indexed citations
10.
Marshall, Scott, Jason S. Hawley, Paul Nyquist, & Thomas J. DeGraba. (2009). The “Ivy Sign” of Adult Moyamoya Disease. The Neurologist. 15(6). 367–368. 7 indexed citations
11.
Plumlee, Marlene, Darrell Brown, & Scott Marshall. (2008). The Impact of Voluntary Environmental Disclosure Quality on Firm Value. SSRN Electronic Journal. 35 indexed citations
12.
Tunblad, Karin, Lars Lindbom, Lynn McFadyen, et al.. (2008). The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data. Journal of Pharmacokinetics and Pharmacodynamics. 35(5). 503–526. 27 indexed citations
13.
Neuberger, J, P. Neuhaus, Jacques Pirenne, et al.. (2008). Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT’ Study. American Journal of Transplantation. 9(2). 327–336. 203 indexed citations
14.
Marshall, Scott, Darrell Brown, & Marlene Plumlee. (2007). 'Negotiated' Transparency? Corporate Citizenship Engagement and Environmental Disclosure. PDXScholar (Portland State University). 342. d689–d689. 16 indexed citations
15.
Brown, Darrell, Jesse Dillard, & Scott Marshall. (2006). Triple Bottom Line: A Business Metaphor for a Social Construct. 2. 46 indexed citations
16.
Marshall, Scott, et al.. (2006). Role of Mechanistically-Based Pharmacokinetic/Pharmacodynamic Models in Drug Development. Clinical Pharmacokinetics. 45(2). 177–197. 27 indexed citations
17.
Jonsson, E. Niclas, Fiona Macintyre, Ian James, Michael Krams, & Scott Marshall. (2005). Bridging the Pharmacokinetics and Pharmacodynamics of UK-279,276 Across Healthy Volunteers and Stroke Patients Using a Mechanistically Based Model for Target-Mediated Disposition. Pharmaceutical Research. 22(8). 1236–1246. 16 indexed citations
18.
Jönsson, Fredrik, Scott Marshall, Michael Krams, & E. Niclas Jonsson. (2005). A Longitudinal Model for Non-Monotonic Clinical Assessment Scale Data. Journal of Pharmacokinetics and Pharmacodynamics. 32(5-6). 795–815. 6 indexed citations
19.
Marshall, Scott. (2003). Validating California Teachers Study Self-Reports of Recent Hospitalization: Comparison with California Hospital Discharge Data. American Journal of Epidemiology. 158(10). 1012–1020. 19 indexed citations
20.
Milligan, Peter A., Scott Marshall, & Mats O. Karlsson. (2002). A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction. British Journal of Clinical Pharmacology. 53(s1). 45S–52S. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel Owen Breakdown of academic impact, for papers by Frank L. Douglas Breakdown of academic impact, for papers by Robert Obermaier Breakdown of academic impact, for papers by Richard A. Cohn Breakdown of academic impact, for papers by Rezà F. Saidi Breakdown of academic impact, for papers by Andrew Charlesworth Breakdown of academic impact, for papers by Helén Anderson Breakdown of academic impact, for papers by Shun‐Chiao Chang Breakdown of academic impact, for papers by Vikram Sinha Breakdown of academic impact, for papers by David Lawrence
Rankless by CCL
2026